KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Sales: 2017-2024

Historic Return on Sales for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -43.79%.

  • Aquestive Therapeutics' Return on Sales rose 584.00% to 5.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.24%, marking a year-over-year increase of 584.00%. This contributed to the annual value of -43.79% for FY2024, which is 4363.00% down from last year.
  • Aquestive Therapeutics' Return on Sales amounted to -43.79% in FY2024, which was down 28,043.11% from -0.16% recorded in FY2023.
  • Aquestive Therapeutics' 5-year Return on Sales high stood at -0.16% for FY2023, and its period low was -43.79% during FY2024.
  • Its 3-year average for Return on Sales is -15.03%, with a median of -1.14% in 2022.
  • Its Return on Sales has fluctuated over the past 5 years, first spiked by 1,256bps in 2021, then plummeted by 4,363bps in 2024.
  • Aquestive Therapeutics' Return on Sales (Yearly) stood at -13.95% in 2020, then skyrocketed by 1,256bps to -1.39% in 2021, then grew by 25bps to -1.14% in 2022, then spiked by 99bps to -0.16% in 2023, then slumped by 4,363bps to -43.79% in 2024.